The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis
Open accessAbstract
BACKGROUND: Pulmonary hypertension (PH) is a rare complication of sarcoidosis, although it is not uncommon in advanced disease. METHODS: A retrospective series of 22 sarcoidosis patients (16 men) of mean (SD) age 46 (13) years with PH was divided into two groups depending on the absence (stage 0: n = 2, stage II: n = 4, stage III: n = 1) or presence (n = 15) of radiographic pulmonary fibrosis at the time of PH diagnosis. RESULTS: In both groups PH was moderate to severe and there was no response to acute vasodilator challenge. In non-fibrotic cases no other cause of PH was found, suggesting a specific sarcoidosis vasculopathy, although no histological specimens were available. In cases with fibrosis there was no correlation between haemodynamics and lung volumes or arterial oxygen tensions, suggesting other mechanisms for PH in addition to pulmonary destruction and hypoxaemia. These included extrinsic arterial compression by lymphadenopathies in three cases and histologically proven pulmonary veno-occlusive disease in the five patients who underwent lung transplantation. Ten patients received high doses of oral prednisone for PH (stage 0: n = 1, stage II: n = 4 and stage IV: n = 5); three patients without pulmonary fibrosis experienced a sustained haemodynamic response. Survival of the overall population was poor (59% at 5 years). Mortality was associated with NYHA functional class IV but not with haemodynamic parameters or with lung function. CONCLUSION: Two very different phenotypes of sarcoidosis combined with PH are observed depending on the presence or absence of pulmonary fibrosis. PH is a severe complication of sarcoidosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of Pulmonary Arterial Hypertension
Humbert, M., Sitbon, O., & Simonneau, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040291 · Cited by 1,707
Standardized lung function testing.
Thornton, J. C., & Miller, A. (1984) · PubMed · Cited by 1,310
Currie, P. J., Seward, J. B., Chan, K.-L., Fyfe, D. A., Hagler, D. J., Mair, D. D., Reeder, G. S., Nishimura, R. A., & Tajik, A. J. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80477-0 · Cited by 1,002
Mayock, R. L., Bertrand, P., Morrison, C. E., & Scott, J. H. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90165-7 · Cited by 800
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis
OLSCHEWSKI, H., ARDESCHIR GHOFRANI, H., WALMRATH, D., SCHERMULY, R., TEMMESFELD-WOLLBRÜCK, B., GRIMMINGER, F., & SEEGER, W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9810008 · Cited by 410
Prognostic Factors Predicting the Outcome of Sarcoidosis: An Analysis of 818 Patients
(1983) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067778 · Cited by 328
Sitbon, O., Humbert, M., Jagot, J., Taravella, O., Fartoukh, M., Parent, F., Herve, P., & Simonneau, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12020265 · Cited by 301
Sarcoidosis with Pulmonary Fibrosis: CT Patterns and Correlation with Pulmonary Function
Abehsera, M., Valeyre, D., Grenier, P., Jaillet, H., Battesti, J. P., & Brauner, M. W. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.6.1741751 · Cited by 293
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics: Table. 1—
Shorr, A. F., Helman, D. L., Davies, D. B., & Nathan, S. D. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00083404 · Cited by 290
Cited by
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Spagnolo, P., Rossi, G., Trisolini, R., Sverzellati, N., Baughman, R. P., & Wells, A. U. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30064-x · Cited by 949
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Feltes, T. F., Bacha, E., Beekman, R. H., Cheatham, J. P., Feinstein, J. A., Gomes, A. S., Hijazi, Z. M., Ing, F. F., de Moor, M., Morrow, W. R., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31821b1f10 · Cited by 853
Metadata
- Authors
- Nunes, H.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2005-10-21
- Volume
- 61
- Issue
- 1
- Pages
- 68-74
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2017814194
- Cited by
- 420
- References
- 26
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. https://app.cochat.ai/papers/10.1136/thx.2005.042838
- The paper
- Nunes, H. (2005). Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax. https://doi.org/10.1136/thx.2005.042838
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.